Skip to main content
Log in

Canthaxanthin retinopathy

An investigation by light and electron microscopy and physicochemical analysis

  • Original Investigations
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

The eyes of a patient with canthaxanthin retinopathy were obtained at autopsy and examined by light and electron microscopy. Various tissues of one eye were also studied by physicochemical methods. Morphologically, there were red, birefringent, lipid-soluble crystals in the inner layers of the entire retina. They were particularly large and numerous perifoveally, where they were also clinically visible, but they also occurred frequently in a ring-shaped form peripherally and, less frequently, equatorially. The crystals were located in a spongy degeneration of the inner neuropil, where atrophy of the inner parts of the Müller cells was noticed. The compound isolated from the retina was identical with synthetic canthaxanthin according to mass and proton-resonance spectroscopy. Quantitatively, the retina contained up to 42 μg canthaxanthin per gram of tissue besides a minor amount of other carotenoids. Of the other tissues of the eye, only the ciliary body contained measurable concentrations of canthaxanthin. From the great number and size of the crystals, on the one hand, and the relatively small amount of isolated canthaxanthin on the other, it was concluded that the crystals presumably represent a canthaxanthin-lipoprotein complex rather than pure canthaxanthin alone. Examination showed that clinically, only the central portion of the canthaxanthin thesaurismosis, where crystals are packed most densely, can be seen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531–1535

    Google Scholar 

  • Boudreault G, Cortin P, Corriveau LA, Rousseau AP, Tardif Y, Malenfant M (1983) Le rétinopathie á la canthaxanthine. 1. Etude clinique de 51 consommateurs. Can J Ophthalmol 18:325–328

    Google Scholar 

  • Cortin P, Corriveau LA, Rousseau AP, Tardif Y, Malenfant M, Boudreault G (1982) Maculopathie en paillettes d'or. Can J Ophthalmol 17:103–106

    Google Scholar 

  • Cortin P, Boudreault G, Rousseau AP, Tardif Y, Malenfant M (1984) La rétinopathie á la canthaxanthine. 2. Facteurs prédisposants. Can J Ophthalmol 19:215–219

    Google Scholar 

  • Daicker B (1978) Die fleckige fettige Degeneration der Netzhautperipherie. Eine Form der „Schneckenspuren“. Graefe's Arch Clin Exp Ophthalmol 205:147–155

    Google Scholar 

  • Foos RY (1972) Vitreoretinal juncture, topographical variations. Invest Opthalmol 11: 801–809

    Google Scholar 

  • Franco JL, Adenis JP, Mathon C, Lebraud P (1985) Un nouveau cas de maculopathie en paillettes d'or. Bull Soc Ophthalmol Fr 85:1035–1037

    Google Scholar 

  • Hennekes R, Weber U, Küchle HJ (1985) Über Canthaxanthinschäden der Netzhaut. Z Prakt Augenheilkd 6:7–9

    Google Scholar 

  • Jakobiec FA (1982) Ocular anatomy, embryology and teratology. Harper & Row, Philadelphia, p 490

    Google Scholar 

  • Kaiser-Kupfer MI, Kupfer C, Rodrigues MM (1981) Tamoxifen retinopathy. Ophthalmology 88:83–89

    Google Scholar 

  • McGuiness R, Beaumont P (1985) Gold dust retinopathy after the ingestion of canthaxanthin to produce skin-bronzing. Med J Aust 143:622–623

    Google Scholar 

  • Metge P, Maudirac-Bonnefoy C, Bellaube P (1984) Thésaurismose rétinienne à la canthaxanthine. Bull Mem Soc Fr Ophtalmol 95:547–549

    Google Scholar 

  • Meyer JJ, Bermond P, Pournaras C, Zoganas L (1985) Canthaxanthin. Langzeiteinnahme und Sehfunktionen beim Menschen. Dtsch Apoth Z 125:1053–1057

    Google Scholar 

  • Philipp W (1985) Carotinoid-Einlagerungen in der Netzhaut. Klin Monatsbl Augenheilkd 187: 439–440

    Google Scholar 

  • Poh-Fitzpatrick MB, Barbera LG (1984) Absence of crystalline retinopathy after long-term therapy with β-carotene. J Am Acad Dermatol 11:111–113

    Google Scholar 

  • Puissant A (1984) La carotinodermie et la pilule à bronzer. Journée Ann Nutr Diet (Paris) 25:1–4

    Google Scholar 

  • Ros AM, Leyon H, Wennersten G (1985) Crystalline retinopathy in patients taking an oral drug containing canthaxanthine. Photodermatology 2:183–185

    Google Scholar 

  • Rousseau A (1983) Canthaxanthine deposits in the eye. J Am Acad Dermatol 8:123–124

    Google Scholar 

  • Saraux H, Laroche L (1983) Maculopathie à papillottes d'or après absorption de canthaxanthine. Bull Soc Ophtalmol Fr 83:1273–1275

    Google Scholar 

  • Tronnier H (1984) Zur Schutzwirkung von β-Carotin und Canthaxanthin gegen UV-Reaktionen der Haut. Z Hautkr 59:859–870

    Google Scholar 

  • Weber U, Goerz G (1985) Augenschäden durch Carotinoid-Einnahme. Dtsch Ärztebl 82:181–182

    Google Scholar 

  • Weber U, Goerz G (1986) Carotinoid-Retinopathie. III. Reversibilität. Klin Monatsbl Augenheilkd 188: 20–22

    Google Scholar 

  • Weber U, Goerz G, Hennekes R (1985a) Carotinoid-Retinopathie. I. Morphologische und funktionelle Befunde. Klin Monatsbl Augenheilkd 186:351–354

    Google Scholar 

  • Weber U, Hennekes R, Goerz G (1985b) Cartinoid-Retinopathie. II. Elektrophysiologische Befunde bei 23 Carotinoid-behandelten Patienten. Klin Monatsbl Augenheilkd 187:507–511

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daicker, B., Schiedt, K., Adnet, J.J. et al. Canthaxanthin retinopathy. Graefe's Arch Clin Exp Ophthalmol 225, 189–197 (1987). https://doi.org/10.1007/BF02175448

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02175448

Keywords

Navigation